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Zinc-Dysprosium functionalized amyloid fibrils 
Stavroula I. Sampani,a Youssra K. Al-Hilaly,a,b Sharali Malik,c Louise C. Serpell*a and George E. 
Kostakis*a
The heterometallic Zn2Dy2 entity bearing partially saturated 
metal centres covalently decorates a highly ordered amyloid 
fibril core and the functionalised assembly exhibits catalytic 
Lewis acid behaviour. 
Amyloid fibrils represent a class of self-assembled peptides that 
share a very well ordered, cross-β core structure and are 
suitable for further decoration.1 Although amyloid is well known 
for a pathological role in diseases such as Alzheimer’s disease 
and Diabetes type 2, short self-assembling peptides have been 
developed and characterised as templates for 
functionalisation.2–4 Hexapeptides have been particularly useful 
in forming highly ordered amyloid cores and several of these 
have been characterised to provide structural information. X-
ray fibre diffraction, transmission electron microscopy have 
been combined to provide a cross-β structural model for the 
self-assembling peptide sequence HIS-TYR-PHE-ASN-ILE-PHE 
(HYFNIF),5 HYFNIF along with several other hexapeptides was 
first identified as a highly amyloidogenic peptide sequence 
using the amyloid propensity algorithm WALTZ.6 This amyloid-
forming peptide contains several side chains that are ideal for 
further functionalisation. Peptides containing histidine residues 
are the most widely studied in coordination chemistry, due to 
their presence in many important metalloproteins.7 
 Functionalisation of these entities with metals depends on 
several parameters, i.e. lability of metal centres, use of protic 
solvents, and the presence of other amino acids with specific 
coordinating side chains, such as Asn, Glu and Met.8,9 Recently, 
the successful self-assembly of biomolecules and metal centres 
has yielded various supramolecular architectures10 i.e. 
macrocycles, cages, metal-organic frameworks,11–15 spherical 
shells or fibrils,16,17 of which some exhibit biomimetic functions 
such as selective recognition18 and allosteric cooperativity.19  
 In protic solvents, we have established the structural 
integrity and the transformative character, of the bimetallic 
entity [ZnII2DyIII2L4(NO3)2(DMF)2] (Zn2Dy2) (Figure 1, left).20,21 
The Zn2Dy2 entity is centrosymmetric and can be considered as 
an ideal moiety to bind with histidine containing biomolecules 
because is a) built solely by the organic ligands which partially 
saturate the coordination environment of all metal centres (the 
remaining sites are occupied by exchangeable solvent and anion 
molecules) and b) the metal centres in the Zn2Dy2 unit are in a 
close proximity (3.3Å); Dy is oxophilic and Zn can coordinate to 
N-atoms, thus permitting either the Zn (A), or Dy (B) or both 
(A&B) centres to bind to one or two positions in the biomolecule 
(Figure 1, left). We utilised capped-HYFNIF (Figure 1, right) as 
model peptide to investigate its binding to Zn2Dy2, as it contains 
various binding sites, starting with the histidine in position-1 as 
well as one tyrosine residue in position-2 with the -OH group of 
the phenolic ring. Here we have fully characterised the 
complexation and architecture of the functionalised amyloid 
structure.  
Figure 1. (left) A structure of the Zn2Dy2 entity used for binding; A and B point 
potential binding sites . (right) A ChemDraw representation of the capped-HYFNIF 
molecule used in this study. 
 HYFNIF self-assembles to form amyloid-like fibrils, which are 
characterised by their regular cross-β architecture.5 Capped 
HYFNIF (2mg/ml) forms mature fibrils in H2O after 7 days 
incubation (Figure 2B). CD spectra for HYFNIF in water revealed 
a strong, positive signal at 200 nm which indicates a linear 
dichroism (LD) contribution arising from the alignment of the 
fibrils and this has been previously reported for HYFNIF fibrils.5 
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CD spectra recorded at 0o and 90o confirmed LD arising from 
lateral alignment of the fibrils. CD showed a small signal at 275 
nm (inset, Figure 2A) attributed to the tyrosine residue.  
 
Figure 2. (A) The CD spectra of 2.4 x10-3 M HYFNIF in water at 0° and 90°. The 
signal at 275 nm (CD spectra) is attributed to tyrosine residue. (B) 
Transmission electron microscopy images of HYFNIF amyloid fibres in water. 
(C) CD spectra of HYFNIF untreated (black) and treated with Zn2Dy2 (red), in 
H2O-MeOH and incubated for 24 h at room temperature. (inset) CD spectrum 
of HYFNIF-Zn2Dy2 was collected at 0° and 90°. (D) Transmission electron 
microscopy images of HYFNIF amyloid-like fibres in H2O-MeOH without and 
with Zn2Dy2. 
 
 HYFNIF amyloid-like fibrils were incubated with Zn2Dy2 for 
24 h in aqueous methanol at room temperature and any 
conformational changes were monitored using CD and 
compared to the CD spectrum of HYFNIF in aqueous methanol 
alone (Figure 2C). The CD spectra of HYFNIF in water and 
methanol are similar (black traces, Figure 2A, 2C). However, the 
CD spectrum of Zn2Dy2-treated HYFNIF fibrils in aqueous 
methanol shows the appearance of new signals at 190, 202, 
230, and 238 nm with significantly enhanced contribution from 
the tyrosine residue at 275 nm as well as an increased intensity 
at 202 nm. This enhanced signal indicates changes in the vicinity 
of the tyrosine residue which may suggest the binding of the 
tyrosine residue with the Zn2Dy2 entity. The signal at 202 nm 
belongs to LD contribution as shown by the CD spectra that 
were collected at 0 and 90 deg (inset, Figure 2C). To investigate 
the effect of the Zn2Dy2 entity on the HYFNIF fibrils, 1.26x10-3 M 
HYFNIF fibrils in aqueous methanol were treated with metal 
sources Zn2Dy2 (HYFNIF-Zn2Dy2), Zn(NO3)2.6H2O (HYFNIF-Zn), 
Dy(NO3)3.5H2O (HYFNIF-Dy) or Zn(NO3)2.6H2O/Dy(NO3)3.5H2O 
(HYFNIF-Zn-Dy) and incubated for 24 h at room temperature. 
The CD spectra with Zn, Dy or Zn-Dy alone did not appear to 
show contribution of LD and gave a signal at 218nm consistent 
with β-sheet content and differed significantly from the 
spectrum arising from HYFNIF-Zn2Dy2. (Figure S1). 
 Transmission electron microscopy studies were performed 
to compare the morphology of HYFNIF in aqueous methanol 
and HYFNIF-Zn2Dy2 in aqueous methanol (Figure 2D). These 
show the appearance of very thin fibrils in dense networks after 
one-week incubation, in all cases. HYFNIF in aqueous methanol 
forms ordered fibrils with dimensions of 8.85±0.73 nm STDEV 
short width, 12.69±1.62 nm STDEV long width, and 59.78±8.35 
nm STDEV periodicity compared to HYFNIF-Zn2Dy2 in aqueous 
methanol with dimensions of 9.38±0.57 nm STDEV short width, 
11.99±1.24 nm STDEV long width, and 65.39±12.15 nm STDEV 
periodicity (Figure 2D). Therefore we can conclude that no 
significant morphological difference was observed after 
treating the preformed HYFNIF fibre with Zn2Dy2. 
 X-ray fibre diffraction (XRFD) confirms that the binding of 
Zn2Dy2 to HYFNIF fibrils does not affect the core architecture. X-
ray fibre diffraction patterns were collected for HYFNIF and 
HYFNIF-Zn2Dy2 (Figure 3) showing the characteristic 4.7Å 
reflection on the meridian, arising from the hydrogen-bonded 
β-strands that run perpendicular to the fibre axis and 12 Å signal 
on the equator, arising from the spacing between the β-sheets. 
HYFNIF and the HYFNIF-Zn2Dy2 fibres showed the lower angle 
reflections on the equator at 16 Å and 18 Å respectively, 
possibly suggesting that packing is affected by the introduction 
of the compound (Figure 3).  
 
 
Figure 3. X-ray Fibre diffraction (XFRD) confirms that the decoration of the fibrils 
by Zn2Dy2 does not affect the structure of the core of the amyloid fibrils. 
 
 UV-Vis data were recorded in the region of 190-800 nm. ZnII 
is diamagnetic (3d10), whilst Dy has a 4f9 electronic 
configuration, thus all transitions are very weak and the 
observed peaks are anticipated to correspond to metal-to-
ligand charge transfer (MLCT) bands. Indeed, the UV-Vis 
spectrum of Zn2Dy2 shows a peak in the 400-460 nm region 
which may be attributed to a MLCT band (Figure 4), however 
this peak is shifted by 100nm, at 350 nm, in the HYFNIF-Zn2Dy2 
spectrum (Figure 4, inset). In the UV region, in agreement with 
the CD data, the HYFNIF-Zn2Dy2 exhibits a maximum (at 275 
nm) with significant signal enhancement comparing to the 
maximum exhibited by the HYFNIF. Notably, the Zn2Dy2 entity 
does not show any peak at this area. This peak can be attributed 
to the presence of aromatic tyrosine residues in the fibril (Figure 
4, red and black lines).5 These findings support the successful 
binding of the Zn2Dy2 entity to HYFNIF. Within the region 300-
500 nm, the presence of two minima at 308 and 401 nm and 
one maximum at 347 nm in the HYFNIF-Zn2Dy2 spectrum, 
comparing to the three maxima at 308, 378, 417 nm and a 
minimum at 343 nm of the Zn2Dy2 unit further indicates binding 
of the peptide to the metals of the coordination cluster (inset, 
Figure 4). Strong absorption appeared near 200-240 nm for the 
HYFNIF, while in the same region, Zn-Dy and Dy salts slightly 
induced hypochromicity in the peptide solutions (Figure 4 and 
Figure S3). Previous studies have indicated the spatial structure 
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together with the chirality of the chromophores (C=O,–COOH) 
and auxochromes (–OH, –NH2) of peptides change upon zinc 
binding,22,23 inducing changes in the absorption intensity. 
According to the literature, lanthanides have been found to 
accelerate fibrillation,24 while zinc can inhibit fibril formation25 
and promote intermolecular interactions26 or indirectly 
inhibit/change the binding mode of other metals.27 The latter 
may also occur here, where zinc salt and dysprosium salt co-
exist with HYFNIF (HYFNIF-Zn-Dy). Moreover, bearing in mind 
that Tyr-10 fluorescence is a better tracker for interactions with 
amyloids,28,29 we recorded a set of data (Figure S3). After 24h of 
incubation for HYFNIF and treated HYFNIF, in the area 300-320 
nm, where the characteristic Tyrosine fluorescent emission is 
observed, we identify that HYFNIF exhibits a maximum with 
intensity 345, HYFNIF-metal salts (Zn and Dy) exhibits a 
maximum with intensity 305, whilst the HYFNIF-Zn2Dy2 exhibits 
a maximum with intensity 132. The suppression of the tyrosine 
signal of  HYFNIF-Zn2Dy2 may indicate that Zn2Dy2 binds to the 
Tyrosine. When salts of both metals were incubated with 
HYFNIF, a significant difference in interaction is observed; this 
may signifies the antagonistic behaviour of both metal centres 
for binding or the inhibition of the fibril formation.  
 
Figure 4. UV-Vis spectra of the Zn2Dy2 entity and HYFNIF fibrils treated and 
untreated with Zn/Dy sources in H2O-MeOH, incubated for 24 h at room 
temperature. (inset) The absorption minima at at 308 and 401 nm, the enhanced 
maximum at 275 and the maximum at 347 nm in the HYFNIF-Zn2Dy2 spectrum 
support binding of the coordination cluster to the peptide.  
 
 To further identify the elemental composition of the 
functionalised HYFNIF-Zn2Dy2 entity field emission scanning 
electron microscope studies with energy dispersive X-ray 
spectroscopy (FESEM/EDX) were recorded despite their 
qualitative rather than quantitative character. HYFNIF-Zn2Dy2, 
suspended in Milli-Q H2O˗MeOH, was prepared by pipetting a 
drop onto a polished Si chip and dried overnight at room 
temperature to afford a light yellow film. The measurements 
are summarized in Table S2 and demonstrate the presence of 
Zn, Dy, O, C and N elements and that a 1:1 Zn:Dy ratio is 
reasonable. 
 Furfural and amines yield, via a Lewis acid promoted domino 
reaction, trans-4,5-diaminocyclopent-2-enones (Table 1); this 
synthon is a versatile building block in the synthesis of natural 
products and therefore several methodologies that promote 
this reaction have been developed.30–32 In previous work, we 
developed a bimetallic catalyst that efficiently catalysed this 
transformation.31 To identify the catalytic efficacy of the 
functionalised HYFNIF-Zn2Dy2, several screening experiments 
were performed (Table 1, Entries 1-8). The catalytic conversion 
was performed in a 10-3 M scale and we used environmental 
friendly solvents. From these data, it is evident that the reaction 
is promoted by the metal salts under the present protocol in a 
moderate yield. Then, we tested HYFNIF (Table 1, entry 5), as 
well as combinations of HYFNIF with metal salts (Table 1, entries 
6 – 8). The HYFNIF fibril is not catalytically active, but the small 
conversion may be attributed to the solvent, as this has been 
noted by others32 and our initial experiments (Table 1, entry 1). 
The moderate catalytic performance of the in-situ generated 
HYFNIF-metal salts derivatives (Table 1, entries 6 – 8) and the 
almost identical yields when compared with that of the metal 
salts (Table 1, Entry 4) indicates that the metal salts are 
responsible for the conversion. Then, we tested the 
tetranuclear Zn2Dy2 unit under similar conditions (Table 1, entry 
9), which exhibited very good catalytic behaviour. The 
functionalised HYFNIF-Zn2Dy2 moiety promotes the 
transformation slightly better, when compared with metal salts 
(Table 1, Entry 4) and in situ mixtures (Table 1, Entries 6-8) and 
with full completion after four days (Table 1, entry 10). To 
further validate the potential catalytic efficacy of HYFNIF-
Zn2Dy2 we employed a primary amine, aniline, (Table 1, entry 
11), and the entity was found to be catalytically active with a 
very good yield of product. Notably, simple metal salts such as 
Cu(OTf)2 or Dy(OTf)3 fail to promote this transformation.33,34 It 
is worth noting that the major product of this reaction is the 
open derivative (Stenhouse salt) as we have noted previously, 
which upon acidic treatment yields the closed ring derivative.31 
The present data identify the applicability of the present 
catalytic protocol, i.e mixture of non-protic/protic solvents, 
concentration (10-3 M) and that HYFNIF-Zn2Dy2 is a promising 
Lewis acid candidate that may be used in future studies at a 
nanoscale level. 
 
Table 1. The catalysed formation of trans-4,5-diaminocyclopen-2-enonea.  
 
Entry Catalyst Solventb Amine Yield%c 
1 - A Morpholine 2 
2 - B Morpholine 8 
3 - C Morpholine 8 
4 Zn(NO3)2.6(H2O) + 
Dy(NO3)3.5(H2O) 
C Morpholine 53 
5 HYFNIF C Morpholine 2 (3d) 
6 HYFNIF + Zn(NO3)2.6(H2O) C Morpholine 56 
7 HYFNIF + Dy(NO3)3.5(H2O) C Morpholine 57 
8 HYFNIF + Zn(NO3)2.6(H2O) + 
Dy(NO3)3.5(H2O) 
C Morpholine 58 
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9 Zn2Dy2 C Morpholine 95 
10 HYFNIF-Zn2Dy2 C Morpholine 67(100d) 
11 HYFNIF-Zn2Dy2 C Aniline 84(100d) 
a Room Temperature, concentration 3mM, 1% Catalyst loading, using the working 
peptide solutions of 1.26x10-3 mol/L in HYFNIF, Total volume (0.25mL), Time 24h, 
Ambient conditions. bSolvent: A = MeOH, B = MeCN, C = MeCN/MeOH (4/1). 
cCalculated by 1H-NMR, based on the conversion of furfural. d After 96 hours.  
Protic solvents are strong coordinating ligands, which may 
occupy the coordination sites of the metal centres or favour 
metal hydrolysis, leading to unsuccessful binding or quench of 
the desired property. Moreover, terminally acetylated peptides 
containing histidine tend to form imidazole coordinated 
complexes with transition metals in slightly acidic or neutral 
solutions. However, for Zn(II), hydrolysis can mainly be 
observed in basic solutions.35 Ln centres are oxophilic and 
therefore can bind to O atoms, such as the OH group of the 
tyrosine moiety of HYFNIF. Bearing all these in mind, we 
propose a binding model of HYFNIF through the N atom of His 
(Zn) and possibly through the neighbouring –OH group of Tyr 
(Dy), shown in Figure 5 and possible coordination mode(s) of 
the ligand (Fig S4).  
 
 
Figure 5. Proposed model of the HYFNIF-Zn2Dy2 fibrils.  
In summary, the present study demonstrates the successful 
implementation of a well-known Zn2Dy2 molecular robust entity 
in decorating an amyloid HYFNIF core. Despite the significant 
flexibility the Zn2Dy2 moiety possesses and the use of protic 
solvent for the assembly, a successful binding to HYFNIF fibril is 
observed. Furthermore, despite harsh solvents used, the 
HYFNIF fibril architecture remains stable and unchanged as a 
core template. The success of the proposed methodology is 
attributed to the limited coordination sites in the Zn2Dy2 entity 
available for coordination with HYFNIF and the presence of 
histidine groups (N-donor atoms), thus paving the way for 
future development. A range of techniques have been used to 
validate this notion. Interestingly, the resulting functionalized 
entity HYFNIF-Zn2Dy2 was found to promote the Lewis acidic 
transformation of furfural and amines to yield the 
corresponding cyclopentenones. These very promising results 
open new avenues for several research fields including 
Coordination Chemistry, Biochemistry and Catalysis.  
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